Wegovy's maker, Novo Nordisk ... "We will see if Eli Lilly and Novo [Nordisk] come to the table and want to make these widely ...

Novo Nordisk shares rose Monday as the company said it would present new data on the ability of semaglutide, the active ingredient in its weight-loss drugs Ozempic and Wegovy, to lower heart risks.

Wegovy's maker, Novo Nordisk ... "We will see if Eli Lilly and Novo [Nordisk] come to the table and want to make these widely available, or if they're going to prioritize high prices and short ...